Physician profile
James T Doss
NPI 1447423793
$3,092.79
in general payments reported to CMS, 2019-2025
13 companies · $558 in 2025
The $558 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $13.25 · 2021: $145 · 2022: $325 · 2023: $813 · 2024: $967 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,320 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,320.38 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $678.57 | 2023-2025 | Tecnis Iol, Catalys System, Tecnis Simplicity |
| Bausch & Lomb Americas INC. | $379.83 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $367.25 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $317.72 | 2022-2025 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $270.57 | 2019-2023 | |
| Harrow Eye, LLC | $233.74 | 2024 | Vevye |
| Alcon Vision LLC | $220.91 | 2019-2025 | Tryptyr |
| Sun Pharmaceutical Industries INC. | $196.91 | 2019-2024 | Cequa |
| Rxsight INC | $176.09 | 2023-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Allergan, INC. | $108.41 | 2021-2022 | |
| Rayner Intraocular Lenses Limited | $56.31 | 2022-2024 | Omidria, Rayone Aspheric, Rayone Emv |
| Abbvie INC. | $52.17 | 2022 | |
| Sight Sciences, INC. | $34.31 | 2021-2024 | Omni Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Doss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.